Earnings Per Share
EPS (Basic)
Pfizer EPS (Basic) increased by 21.6% to $0.62 in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 21.5%, from $0.79 to $0.62. Over 2 years (FY 2021 to FY 2024), EPS (Basic) shows a downward trend with a -40.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Detailed definition
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Peer comparison
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
Metric ID:
is_eps_basicHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.98 | $1.42 | $0.67 | $1.37 | $1.73 | $1.51 | $0.86 | $0.97 | $0.41 | -$0.42 | $0.55 | $0.01 | $0.79 | $0.06 | $0.52 | $0.51 | $0.62 |
| QoQ Change | — | +44.9% | -52.8% | +104.5% | +26.3% | -12.7% | -43.0% | +12.8% | -57.7% | -202.4% | +231.0% | -98.2% | >999% | -92.4% | +766.7% | -1.9% | +21.6% |
| YoY Change | — | — | — | — | +76.5% | +6.3% | +28.4% | -29.2% | -76.3% | -127.8% | -43.3% | -97.6% | +288.1% | — | -5.5% | >999% | -21.5% |
Range-$0.42 – $1.73
CAGR-10.8%
Avg YoY Growth+416.5%
Median YoY Growth-13.5%
EPS (Basic) at Other Companies
Frequently Asked Questions
- What is Pfizer's eps (basic)?
- Pfizer (PFE) reported eps (basic) of $0.62 in Q3 2025.
- How has Pfizer's eps (basic) changed year-over-year?
- Pfizer's eps (basic) decreased by 21.5% year-over-year, from $0.79 to $0.62.
- What is the long-term trend for Pfizer's eps (basic)?
- Over 2 years (2021 to 2024), Pfizer's eps (basic) has grown at a -40.1% compound annual growth rate (CAGR), from $3.93 to $1.41.
- What does eps (basic) mean?
- The amount of profit a company makes for every single share of its common stock currently held by investors.